Literature DB >> 33629540

Asthma increases long-term revision rates of endoscopic sinus surgery in chronic rhinosinusitis with and without nasal polyposis.

Amarbir S Gill1, Kristine A Smith2, Huong Meeks3, Gretchen M Oakley1, Karen Curtin3,4, Laurie LeClair5, Heather Howe5, Richard R Orlandi1, Jeremiah A Alt1.   

Abstract

BACKGROUND: Chronic rhinosinusitis with asthma (CRS-A) has a significant impact on patient morbidity and quality of life. Nevertheless, little is known about the natural history of endoscopic sinus surgery (ESS) in this cohort. The objective of this study was to evaluate revision rates of ESS in CRS-A and identify risk factors associated with increased likelihood for revision surgery compared to those with CRS without asthma (CRS-alone).
METHODS: The Utah Population Database was queried for patients age >18 years with CRS who underwent at least 1 ESS between 1996 and 2018. Demographic information and history of ESS were collected and compared between CRS-A and CRS-alone using chi-square tests for categorical variables and t tests for continuous variables. Risk factors for revision surgery were analyzed using Cox proportional hazard models.
RESULTS: A total of 33,090 patients (7693 CRS-A and 25,397 CRS-alone) were included in the final analysis. Mean follow up was 9.8 years in CRS-A and 9.1 years in CRS-alone (p < 0.001). The revision rate among patients with CRS-A (21.5%) was twice that of CRS-alone (10.8%) (p < 0.001). Among patients with CRS, a history of allergy (p < 0.001), asthma (p < 0.001), and nasal polyposis (p < 0.001) was independently associated with increased risk of revision ESS. Patients with CRS-A and nasal polyposis were 6 times more likely to require revision surgery than those with CRS-alone (p < 0.010).
CONCLUSION: The rate of revision ESS in CRS-A was twice that of CRS-alone; patients with CRS-A and nasal polyposis were 6 times more likely to require revision than those with CRS-alone. ©2021 ARSAAOA, LLC.
© 2021 ARS-AAOA, LLC.

Entities:  

Keywords:  asthma; chronic rhinosinusitis; endoscopic sinus surgery; nasal polyposis; revision surgery

Mesh:

Year:  2021        PMID: 33629540      PMCID: PMC8316255          DOI: 10.1002/alr.22779

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   5.426


  21 in total

1.  Evaluation of Quality of Life and Pattern of Improvement of Bronchial Asthma in Chronic Rhinosinusitis Patients Treated by Functional Endoscopic Sinus Surgery.

Authors:  S Sujatha; V Suja
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-01-22

2.  Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype.

Authors:  Amar Miglani; Rohit D Divekar; Antoine Azar; Matthew A Rank; Devyani Lal
Journal:  Int Forum Allergy Rhinol       Date:  2018-05-31       Impact factor: 3.858

Review 3.  Chronic rhinosinusitis: Epidemiology and burden of disease.

Authors:  Adam S DeConde; Zachary M Soler
Journal:  Am J Rhinol Allergy       Date:  2016 Mar-Apr       Impact factor: 2.467

4.  Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.

Authors:  Whitney W Stevens; Anju T Peters; Annemarie G Hirsch; Cara M Nordberg; Brian S Schwartz; Dione G Mercer; Mahboobeh Mahdavinia; Leslie C Grammer; Kathryn E Hulse; Robert C Kern; Pedro Avila; Robert P Schleimer
Journal:  J Allergy Clin Immunol Pract       Date:  2017-03-09

5.  Revision rates and time to revision following endoscopic sinus surgery: A large database analysis.

Authors:  Nathan R Stein; Aria Jafari; Adam S DeConde
Journal:  Laryngoscope       Date:  2017-07-08       Impact factor: 3.325

Review 6.  Chronic rhinosinusitis, race, and ethnicity.

Authors:  Zachary M Soler; Jess C Mace; Jamie R Litvack; Timothy L Smith
Journal:  Am J Rhinol Allergy       Date:  2012 Mar-Apr       Impact factor: 2.467

7.  Cystic fibrosis and endoscopic sinus surgery: Relationship between nasal polyposis and likelihood of revision endoscopic sinus surgery in patients with cystic fibrosis.

Authors:  Scott Rickert; Victoria E Banuchi; Joan D Germana; Michael G Stewart; Max M April
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-10

8.  Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment.

Authors:  Gretchen M Oakley; Karen Curtin; Quinn Orb; Carole Schaefer; Richard R Orlandi; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2015-02-12       Impact factor: 3.858

9.  Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery.

Authors:  R B Moss; V V King
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-05

Review 10.  An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma.

Authors:  Riccardo Castagnoli; Amelia Licari; Ilaria Brambilla; Mariangela Tosca; Giorgio Ciprandi; Gian Luigi Marseglia
Journal:  Expert Rev Respir Med       Date:  2020-09-02       Impact factor: 3.772

View more
  4 in total

1.  The Long-Term Effects of Budesonide Nasal Irrigation in Chronic Rhinosinusitis with Asthma.

Authors:  Seon Min Jung; Jin Hye Kwak; Moo Keon Kim; Kyung Tae; Seok Hyun Cho; Jin Hyeok Jeong
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

2.  The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland.

Authors:  Sanna Toppila-Salmi; Jenni Hällfors; Juhani Aakko; Bettina Mannerström; Kaisa Nieminen; Gunilla Telg; Lauri Lehtimäki
Journal:  Clin Transl Allergy       Date:  2022-10-09       Impact factor: 5.657

3.  Host and Surgical Factors Affecting the Frequency and Duration of Revision Endoscopic Sinus Surgery.

Authors:  Erdinc Cekic
Journal:  Cureus       Date:  2022-09-15

4.  Cumulative comorbidity burden does not worsen outcomes in management of chronic rhinosinusitis.

Authors:  Amarbir S Gill; Jess C Mace; Ryan Rimmer; Vijay R Ramakrishnan; Daniel M Beswick; Zachary M Soler; James Manor; Richard R Orlandi; Timothy L Smith; Jeremiah A Alt
Journal:  Int Forum Allergy Rhinol       Date:  2021-07-14       Impact factor: 3.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.